-
Trial to Test Drug Combination for Hospital Infections
A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities.
-
ALS Soy Peptide Trial Completes Enrollment
A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants.
-
Google Acquires Visual Interaction Tech Company
Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes.
-
3-D Printing Creates Heart-on-Chip with Sensors
Biomedical engineers at Harvard University developed a programmable and automated process for creating miniature organs on chips with integrated sensors using 3-D printing.
-
On the Road Again
We’ll be traveling for the rest of the week, so Science & Enterprise will not have any posts tomorrow or Friday.
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.
-
Virtual Reality Game in Development for Vision Disorder
An engineering lab at New Jersey Institute of Technology is creating a virtual reality therapy game to treat children with binocular vision dysfunction.
-
Mobile Multichannel Biomarker Detector Designed
An engineering lab designed a portable testing device connected to a smartphone that can analyze multiple specimen samples for a leading cancer biomarker.
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
Clinical Trial Network for Lupus Formed
A network of medical researchers is being assembled to conduct clinical trials to test new therapies for lupus and drugs approved for other disorders that may also treat the disease.